Director – Organizational Development Partner
Revolution Medicines
Director – Organizational Development Partner
Revolution Medicines
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Revolution Medicines is seeking an experienced Director, Organizational Development Partner to serve as the primary organizational development and effectiveness (OD&E) consulting partner to our Research and Development functions. This individual contributor role will partner with senior leaders and Human Resources Business Partners (HRBPs) to diagnose organizational needs, strengthen leadership and team effectiveness, and guide organization design and change initiatives. The Director will design and deliver high-impact sessions, engage external specialists when appropriate, and develop reusable tools that enable leaders and HRBPs to address common needs at scale. This role reports to the Senior Director, Organizational Development & Effectiveness and is based at our Redwood City headquarters.
Responsibilities:
Lead OD&E consulting engagements for Clinical Development and Research, aligning scope, outcomes and interventions with functional business priorities and HRBP partners.
Conduct organizational diagnostics through stakeholder interviews, data review and facilitated assessment; synthesize findings and recommend practical improvements to structure, roles, decision rights and operating rhythms.
Consult on organization design, leadership transitions, cross-functional collaboration and significant organizational changes; support leaders in planning and implementing effective transitions.
Design and facilitate leadership-team and team-effectiveness engagements, including new leader/team integration, strategic offsites, team charters, operating principles, conflict navigation and alignment sessions.
Provide targeted leadership coaching and consultation; partner with HRBPs and the OD&E team to connect leaders with external coaching resources when appropriate.
Use evidence-informed OD methodologies and assessment tools to strengthen team awareness, trust, collaboration and execution.
Partner with Learning & Development and Culture & Engagement to connect functional needs to existing RevMed programs, tools, values and leadership frameworks.
Build and refine reusable OD resources, diagnostics, facilitator guides and HRBP toolkits that support consistent delivery and appropriate self-service.
Enable HRBPs through case consultation, co-design and selective co-facilitation, while maintaining clear boundaries with HRBP and Employee Relations responsibilities.
Scope and oversee assigned external OD consultants and facilitators, ensuring clear deliverables, quality, confidentiality and alignment with RevMed standards.
Define engagement objectives and measures, gather stakeholder feedback, assess follow-through and share organizational insights with the Senior Director and HR partners.
Manage a portfolio of concurrent engagements and coordinate tracking, logistics and reporting with OD&E program operations support.
Required Skills, Experience and Education:
Bachelor’s degree in organizational development, industrial/organizational psychology, human resources, business or a related discipline, or equivalent relevant experience.
10+ years of progressive experience in organizational development, organizational effectiveness, leadership development or internal/external organizational consulting.
Demonstrated success advising senior leaders and HRBPs on complex organizational and team challenges.
Strong hands-on experience in organizational diagnosis, organization design, team effectiveness, facilitation and change management.
Ability to design and facilitate high-impact leadership and cross-functional team sessions and translate diagnostic insights into practical recommendations.
Effective leadership coaching and consulting skills, including sound judgment in sensitive or confidential situations.
Strong stakeholder influence, communication, project management and analytical skills; ability to manage multiple priorities in a fast-paced, matrixed environment.
Experience developing and applying practical OD tools, frameworks and measures of engagement effectiveness.
Preferred Skills:
Advanced degree in organizational development, industrial/organizational psychology, organizational behavior or a related field.
Experience in biotechnology, pharmaceuticals, life sciences or scientific and technical organizations, particularly Research, Manufacturing or Clinical Development.
Certification in Insights Discovery, Organizational Design Frameworks, Team Diagnostics such as Peter Hawkin’s model, ADKAR, or Change Navigator
Experience with global, matrixed organizations, alliances and cross-functional development teams.
Experience building scalable HRBP enablement resources and managing external OD consultants or facilitators.
#LI-TS1 #LI-Hybrid
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Base Pay Salary Range 211000 - 264000 USD
Clinical-stage oncology company developing RAS inhibitors
Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.
Explore more opportunities at Revolution Medicines